Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing.

PLoS One · 2017 · PMC5570333 · PMID 28837681

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Tumor volume at the end of the study (day 21) showed a highly significant growth inhibition with the EGFR BiTE ® vs.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.